Utilisation : Ce produit est destiné uniquement à la recherche.
Toutes les informations sur les produits présentes sur ce site sont fournies à titre éducatif uniquement. Toute forme d’introduction dans le corps humain ou animal est strictement interdite par la loi. Ce produit doit être manipulé uniquement par des professionnels agréés et qualifiés. Il ne s’agit pas d’un médicament, d’un aliment ou d’un cosmétique et il ne doit pas être présenté, utilisé ou étiqueté comme tel.
RAD-140 + MK-677 + YK-11 Value Pack
What's included
- 1 × RAD-140 (Testolone), (10mg/capsule) 60 Capsules
- 1 × MK-677 (Ibutamoren), (10mg/capsule) 60 Capsules
- 1 × YK-11 (5mg/capsule), 60 Capsules
Pendant notre changement d’emballage, vous pouvez recevoir des produits avec l’ancienne ou la nouvelle étiquette. La formulation, la pureté et la qualité restent exactement les mêmes, selon nos standards.
- Carte de crédit
- Virement bancaire (SEPA instantané)
- Virement bancaire (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Autres
-25% sur tout – jusqu’au 31 octobre
25% sur les prix habituels, en remplacement des autres soldes. Cumulable uniquement avec la remise crypto.
Expédition le jour même pour les commandes aux États-Unis passées avant 12 h EST.
Voir la politique de livraison →Chaque lot est testé pour sa pureté, sa puissance et sa qualité.
Voir les résultats d’analyse →This research value pack combines three synthetic compounds frequently studied together in selective receptor and growth signalling pathway research: RAD-140 (Testolone), a non-steroidal selective receptor modulator; MK-677 (Ibutamoren), studied for growth hormone secretagogue properties; and YK-11, studied for its proposed interactions with myostatin-related signalling pathways.
Combined research models allow investigation into how selective receptor modulation, growth hormone secretagogue signalling, and myostatin pathway interactions may intersect within body composition and growth-related signalling research.
Research applications include comparative selective receptor pathway studies, multi-compound growth signalling research, and experimental protocol design using all three compound classes.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Synonyms | RAD-140 + MK-677 + YK-11 Value Pack |
|---|---|
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What distinct research pathways does each compound in this value pack address?
RAD-140 is studied for non-steroidal selective receptor modulator activity at androgen receptor binding sites, MK-677 for growth hormone secretagogue properties via GHS-R1a receptor engagement and downstream IGF-1 axis signalling, and YK-11 for proposed interactions with myostatin-related signalling pathways. Combined research protocols allow investigators to examine how these three distinct mechanisms may interact within shared experimental models examining body composition and growth-related signalling.
What experimental models are used to study this combination's effects on growth-related signalling pathways?
Cell-based receptor binding assays for RAD-140, growth hormone and IGF-1 pathway signalling measurements for MK-677, and myostatin-related gene expression assays (such as follistatin and myostatin pathway markers in myoblast or muscle cell models) for YK-11 are standard methods for studying this three-compound combination, typically compared across single-compound and combined-compound treatment arms relative to vehicle controls.
How should researchers structure comparative protocols using this three-compound value pack?
Factorial or staggered experimental designs incorporating single-compound, paired-compound, and full three-compound treatment arms allow researchers to isolate the contribution of each compound and identify any combination-specific effects on selected receptor and growth signalling endpoints, a standard approach when studying multi-pathway compound combinations.